Acid-triggered controlled release and fluorescence-switchable phthalocyanine nanoassemblies combined with O2-economizer for tumor imaging and collaborative photodynamic antitumor therapy
Authors:
- 20 November 2023
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 143, 106986
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2023QH064)
This publication has 27 references indexed in Scilit:
- Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sitesAdvanced Drug Delivery Reviews, 2020
- Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future developmentActa Pharmaceutica Sinica B, 2020
- Active transcytosis and new opportunities for cancer nanomedicineNature Materials, 2020
- Advances in nanomaterials for photodynamic therapy applications: Status and challengesBiomaterials, 2020
- Unimolecular Photodynamic O2-Economizer To Overcome Hypoxia Resistance in PhototherapeuticsJournal of the American Chemical Society, 2020
- Modulation of Intracellular Oxygen Pressure by Dual‐Drug Nanoparticles to Enhance Photodynamic TherapyAdvanced Functional Materials, 2019
- Phthalocyanines as medicinal photosensitizers: Developments in the last five yearsCoordination Chemistry Reviews, 2019
- Oxidative Phosphorylation as an Emerging Target in Cancer TherapyClinical Cancer Research, 2018
- Long-acting injectable atovaquone nanomedicines for malaria prophylaxisNature Communications, 2018
- Rapid killing of bacteria by a new type of photosensitizerApplied Microbiology and Biotechnology, 2017